Differences in Clinical Features and Comorbid Burden between HLA-C*06:02 Carrier Groups in >9,000 People with Psoriasis (2022)

First Author: Douroudis K
Attributed to:  Improving diagnosis and treatment for the quantified patient funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2021.08.446

PubMed Identifier: 34767815

Publication URI: http://europepmc.org/abstract/MED/34767815

Type: Journal Article/Review

Parent Publication: Journal of Investigative Dermatology

Issue: 6

ISSN: 0022-202X